Navigation Links
New HIV Drug May Help Those Resistant to Therapy
Date:4/1/2009

Study in monkeys finds that it reduces replication of the virus,,,,

WEDNESDAY, April 1 (HealthDay News) -- An investigational drug might help people with HIV who don't respond to standard anti-retroviral therapy, a new study suggests.

Currently, the "gold standard" treatment for HIV is known as HAART, for highly active anti-retroviral therapy, which consists of a number of drugs that reduce viral load by stopping the virus from replicating. If it works well, HAART can increase recipients' life expectancy, but it's not effective in about 10 percent of people who take it, partly because some develop resistance to the drugs.

In the study, researchers tested the effectiveness of a molecule called D-1mT and anti-retroviral therapy (ART) in macaque monkeys with simian immunodeficiency virus (SIV), which is similar to HIV in humans. After six days of treatment, only three of the macaques had detectable SIV levels, and after 13 days, only very low SIV levels could be found in two of the macaques.

When the researchers gave D-1mT to eight macaques that were not treated with ART, there was no change in the levels of virus in the blood after 13 days of treatment.

"Our early findings suggest that D-1mT could be used alongside anti-retroviral therapy to stop the virus from replicating," Dr. Adriano Boasso, from Imperial College London, said in a news release from the college.

"The disease can only progress if the virus is replicating, so if we can slow replication down, we can reduce the impact of the disease on the patient's life," Boasso said. "We still need to figure out how D-1mT is working, then we can think about developing this as a potential treatment for HIV."

The study is in the April 1 issue of the Journal of Immunology.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV.



-- Robert Preidt



SOURCE: Imperial College London, news release, March 31, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S.
2. ZEO Health's New Program Offers Answer for Those Looking for Income
3. Mayo Clinic Study Suggests Those Who Have Chronic Pain May Need to Assess Vitamin D Status
4. Mayo Clinic study suggests those who have chronic pain may need to assess vitamin D status
5. New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening
6. Nationwide Medical/Surgical Reveals Their Help Sheet For Those Infected with Influenza Virus
7. Drug Rehab Mountainside Treatment Center is an Effective and Quality Option for Those Seeking Drug Treatment - Located Close to NY MA
8. Bocce Palooza Again Provides Grants and Scholarships to Those With Spinal Cord Injuries
9. Those Who Feel Rejected Direct Hostility Toward Others
10. The SCAN Foundation Funds New Program for Santa Clarita and South Los Angeles Seniors and Those Who Care for Them
11. Hearing Aids Offer Hope for Those Who Suffer from Persistent Ringing in the Ears, Better Hearing Institute Survey Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New HIV Drug May Help Those Resistant to Therapy
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... Philadelphia, PA (PRWEB) , ... February 26, 2017 , ... ... products and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for ... , Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... and Markets has announced the addition of the "Hemophilia Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Hemophilia ... market? What are the unit prices and annual treatment ...
(Date:2/24/2017)... 24, 2017 Medical information groups within ... their self-service capabilities to manage inquiries from external ... New research from consulting leader Best Practices, ... self-service website portals where HCPs can sign on ... of many findings to emerge from the new ...
Breaking Medicine Technology: